# ARL Biopharma, Inc. – FDA Inspection, Mar 25, 2016

Source: https://www.keypedia.com/records/fda_inspections/arl-biopharma-inc/d5a8ac1d-9744-43f0-a76e-6727f2380fa5
Source feed: FDA_Inspections

> FDA inspection 965921 of ARL Biopharma, Inc., March 25, 2016. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 965921
- Company Name: ARL Biopharma, Inc.
- Inspection Date: 2016-03-25
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1322550 - 2026-05-22
- [FDA Inspection 1102393 - 2019-09-20](https://www.keypedia.com/records/fda_inspections/arl-biopharma-inc/00b13fc7-baf0-4864-922b-b9359c7c19bc)
- FDA Inspection 806356 - 2012-11-08
- FDA Inspection 701726 - 2010-11-19
- FDA Inspection 651237 - 2010-02-18

Company: https://www.keypedia.com/companies/arl-biopharma-inc/358f0af9-fe47-4cd8-b43e-a4b9eacf1b21

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c